FEATURED

IDEA25 is a gathering focused on discussing and showcasing the future of nonwoven materials, their applications, and their impact on both form and function across various market sectors. The event is produced by INDA, the Association of the Nonwoven Fabrics Industry.

This initiative marks a world-first accomplishment that is aligned with the practical workflow expected for personalized cancer vaccine therapies

Integrated within the company’s PerSim® medical education and training platform, the patented XR-based technology increases training efficacy by providing a safe and controlled environment that closely resembles authentic patient encounters, allowing students to refine their clinical skills and improve preparedness through real-world scenario simulations.

“There has been far too little effort to raise awareness about atrial fibrillation—the most common arrhythmia and a leading driver of stroke, heart failure, and mortality,” said Dr. Yaariv Khaykin, Chief Medical Officer of Myant. “Atrial Fibrillation leads to impaired quality of life and affects productivity, yet many patients don’t even realize they have it. Some experience palpitations, others just feel fatigued and attribute it to aging. Many physicians remain unaware of innovations in Atrial Fibrillation management that could transform care. Myant Care360, with direct Atrial Fibrillation assessment referrals, provides unprecedented access to specialized care and early intervention—strategies that have been shown in randomized studies to slow or even reverse the progression of Atrial Fibrillation.”

Charm AI Scribe captures the natural dialogue between the patient and provider during a visit and transcribing it in real time.